Literature DB >> 27909530

Implantable Loop Recorder: Diagnostic Yield And Possible Therapeutic Effect In Patients With Neurally Mediated Reflex Syncope.

M Unterhuber1, W Rauhe1, P Sgobino2, F Pescoller1, M Manfrin1, M Tomaino1.   

Abstract

Through a retrospective study concerning the experience of our center in patients affected by Neurally Mediated reflex Syncope (NMS) we wanted to verify not only the diagnostic yield of the Implantable Loop Recorder (ILR) but its possible placebo therapeutic effect. In the context of patients affected by a severe clinical presentation of NMS identified through a careful clinical evaluation, we selected those who followed a diagnostic iter using the ILR. We analysed 84 patients (39 male and 45 female, mean age 71 years), during the period 2009-2013. 34 patients (40.5%) had no recurrences after a mean follow-up (FU) of 35 months, among these 17 concluded a FU of 4 years. 50 patients (59.5%) had recurrences and a specific diagnosis after an average period of 7 months. We found an important number of patients who showed a disappearance of syncope during an observation period of 2-3 and 4 years. At first glance this results could be explained considering the possible placebo therapeutic effect of ILR.

Entities:  

Keywords:  Cardioinhibitory; Neurally Mediated Reflex Syncope; SYNPACE

Year:  2016        PMID: 27909530      PMCID: PMC5129683          DOI: 10.4022/jafib.1398

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  11 in total

1.  Proposed electrocardiographic classification of spontaneous syncope documented by an implantable loop recorder.

Authors:  Michele Brignole; Angel Moya; Carlo Menozzi; Roberto Garcia-Civera; Richard Sutton
Journal:  Europace       Date:  2005-01       Impact factor: 5.214

2.  Guidelines for the diagnosis and management of syncope (version 2009).

Authors:  Angel Moya; Richard Sutton; Fabrizio Ammirati; Jean-Jacques Blanc; Michele Brignole; Johannes B Dahm; Jean-Claude Deharo; Jacek Gajek; Knut Gjesdal; Andrew Krahn; Martial Massin; Mauro Pepi; Thomas Pezawas; Ricardo Ruiz Granell; Francois Sarasin; Andrea Ungar; J Gert van Dijk; Edmond P Walma; Wouter Wieling
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

3.  Assessment of a standardized algorithm for cardiac pacing in older patients affected by severe unpredictable reflex syncopes.

Authors:  Michele Brignole; Fabrizio Ammirati; Francesco Arabia; Fabio Quartieri; Marco Tomaino; Andrea Ungar; Maurizio Lunati; Vitantonio Russo; Attilio Del Rosso; Germano Gaggioli
Journal:  Eur Heart J       Date:  2015-03-29       Impact factor: 29.983

Review 4.  Components of clinical trials for vasovagal syncope.

Authors:  R Sheldon; S Rose
Journal:  Europace       Date:  2001-07       Impact factor: 5.214

5.  Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope.

Authors:  Michele Brignole; Richard Sutton; Carlo Menozzi; Roberto Garcia-Civera; Angel Moya; Wouter Wieling; Dietrich Andresen; David G Benditt; Panos Vardas
Journal:  Eur Heart J       Date:  2006-03-28       Impact factor: 29.983

6.  Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope : pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators.

Authors:  R Sutton; M Brignole; C Menozzi; A Raviele; P Alboni; P Giani; A Moya
Journal:  Circulation       Date:  2000-07-18       Impact factor: 29.690

7.  Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial.

Authors:  Stuart J Connolly; Robert Sheldon; Kevin E Thorpe; Robin S Roberts; Kenneth A Ellenbogen; Bruce L Wilkoff; Carlos Morillo; Michael Gent
Journal:  JAMA       Date:  2003-05-07       Impact factor: 56.272

8.  Standardized algorithm for cardiac pacing in older patients affected by severe unpredictable reflex syncope: 3-year insights from the Syncope Unit Project 2 (SUP 2) study.

Authors:  Michele Brignole; Francesco Arabia; Fabrizio Ammirati; Marco Tomaino; Fabio Quartieri; Martina Rafanelli; Attilio Del Rosso; Maria Rita Vecchi; Vitantonio Russo; Germano Gaggioli
Journal:  Europace       Date:  2015-11-26       Impact factor: 5.214

9.  A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE).

Authors:  Antonio Raviele; Franco Giada; Carlo Menozzi; Giancarlo Speca; Serafino Orazi; Gianni Gasparini; Richard Sutton; Michele Brignole
Journal:  Eur Heart J       Date:  2004-10       Impact factor: 29.983

10.  Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial.

Authors:  Michele Brignole; Carlo Menozzi; Angel Moya; Dietrich Andresen; Jean Jacques Blanc; Andrew D Krahn; Wouter Wieling; Xulio Beiras; Jean Claude Deharo; Vitantonio Russo; Marco Tomaino; Richard Sutton
Journal:  Circulation       Date:  2012-05-07       Impact factor: 29.690

View more
  1 in total

Review 1.  [Indications for loop recorder implantation for syncope].

Authors:  Andreas Schuchert
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-05-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.